Jessica L. Mega, MD, MPH, is a cardiologist at Stanford Health Care and co-founder of Verily, an Alphabet company translating technological innovations and scientific insights into efforts that improve patient outcomes and healthcare. Prior to that, as a faculty member at Harvard Medical School, a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Her findings have been published in the New England Journal of Medicine, Lancet, JAMA, and elsewhere. She has served on the Advisory Group for the California Governor’s Precision Medicine initiative. Dr. Mega currently serves on the Advisory Board for the Duke-Margolis Center for Health Policy and Research!America, and also sits on the Board of Directors for Danaher Corporation.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC).